Assessing the safety of nanomaterials by genomic approach could be another alternative.
Lee
Tin-Lap
TL
Chan
Wai-Yee
WY
Rennert
Owen M
OM
D004353:Drug Evaluation, Preclinical / Q000379:methods*; D005820:Genetic Testing / Q000379:methods*; D023281:Genomics / Q000379:methods*; D049329:Nanostructures / Q000633:toxicity*